MeSH term
Frequency | Condition_Probility | Humans | 508 | 0.0 |
Terminology | 3 | 2.0 |
Adult | 169 | 0.0 |
Aged | 134 | 0.0 |
Antibodies, Neoplasm/analysis | 3 | 10.0 |
Brain Chemistry | 11 | 4.0 |
Brain Neoplasms/*pathology | 11 | 14.0 |
Cell Division/physiology | 5 | 0.0 |
Female | 224 | 0.0 |
Glial Fibrillary Acidic Protein/analysis | 82 | 50.0 |
Immunohistochemistry/methods | 16 | 2.0 |
Male | 243 | 0.0 |
Middle Aged | 163 | 0.0 |
Neoplasm Invasiveness | 4 | 0.0 |
Brain/pathology | 7 | 2.0 |
DNA Mutational Analysis | 2 | 0.0 |
English Abstract | 45 | 0.0 |
Glial Fibrillary Acidic Protein/*genetics | 12 | 54.0 |
Research Support, Non-U.S. Gov't | 284 | 0.0 |
Animals | 153 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
Biological Markers/analysis | 9 | 1.0 |
Enzyme-Linked Immunosorbent Assay | 12 | 0.0 |
Neuroglia/metabolism/*pathology | 3 | 42.0 |
Predictive Value of Tests | 4 | 0.0 |
*S100 Proteins | 2 | 2.0 |
Severity of Illness Index | 9 | 0.0 |
Adolescent | 78 | 0.0 |
Brain Neoplasms/chemistry/*pathology | 3 | 42.0 |
Immunohistochemistry | 195 | 1.0 |
Neoplasm Proteins/analysis | 6 | 1.0 |
S100 Proteins/analysis | 32 | 16.0 |
Thalamus/chemistry/*pathology | 2 | 100.0 |
Actins/analysis | 9 | 4.0 |
Antigens, CD34/analysis | 4 | 0.0 |
Biopsy, Needle | 3 | 0.0 |
Gastrointestinal Neoplasms/chemistry/*pathology | 2 | 25.0 |
Paraffin Embedding | 3 | 1.0 |
Antibodies | 7 | 1.0 |
Astrocytes/chemistry/*metabolism | 3 | 75.0 |
Rats | 70 | 0.0 |
Rats, Sprague-Dawley | 14 | 0.0 |
*Chromosomes, Human, Pair 17 | 3 | 0.0 |
Comparative Study | 76 | 0.0 |
Mice | 54 | 0.0 |
Aged, 80 and over | 48 | 0.0 |
Child | 68 | 0.0 |
Fluorescent Antibody Technique, Indirect | 9 | 1.0 |
Glial Fibrillary Acidic Protein/*metabolism | 22 | 66.0 |
Image Processing, Computer-Assisted | 2 | 0.0 |
Microscopy, Confocal | 9 | 0.0 |
Neuroglia/metabolism | 8 | 11.0 |
Time Factors | 15 | 0.0 |
Tissue Fixation | 5 | 5.0 |
Animals, Genetically Modified | 2 | 0.0 |
Astrocytes/*metabolism | 8 | 12.0 |
Glial Fibrillary Acidic Protein/genetics/*metabolism | 5 | 100.0 |
Organ Specificity | 3 | 0.0 |
Phosphorylation | 8 | 0.0 |
Animals, Newborn | 3 | 0.0 |
Behavior, Animal | 2 | 2.0 |
Cell Count/methods | 2 | 3.0 |
Cell Death/physiology | 2 | 2.0 |
Cells, Cultured | 37 | 0.0 |
Embryo | 3 | 0.0 |
In Vitro | 7 | 0.0 |
Receptors, AMPA/metabolism | 3 | 33.0 |
gamma-Aminobutyric Acid/metabolism | 2 | 6.0 |
Astrocytes/metabolism/pathology | 4 | 14.0 |
Brain Neoplasms/*metabolism/*pathology | 3 | 27.0 |
Child, Preschool | 51 | 0.0 |
Glial Fibrillary Acidic Protein/biosynthesis | 6 | 31.0 |
Infant | 43 | 0.0 |
Intermediate Filament Proteins/*biosynthesis | 2 | 40.0 |
*Nerve Tissue Proteins | 6 | 1.0 |
Actins/metabolism | 7 | 1.0 |
Biological Markers | 15 | 0.0 |
Blotting, Western | 19 | 0.0 |
Carrier Proteins/metabolism | 3 | 0.0 |
Cell Line, Transformed | 2 | 0.0 |
Glial Fibrillary Acidic Protein/metabolism | 78 | 37.0 |
Glutamate-Ammonia Ligase/metabolism | 6 | 54.0 |
Karyotyping | 6 | 0.0 |
Microscopy, Electron, Scanning | 3 | 1.0 |
Retina/*cytology | 3 | 27.0 |
Antigens/metabolism | 2 | 3.0 |
Synaptophysin/metabolism | 3 | 9.0 |
Antibody Specificity | 9 | 0.0 |
Astrocytoma/*immunology | 2 | 100.0 |
Blood-Brain Barrier | 3 | 5.0 |
Blotting, Northern | 8 | 0.0 |
Glial Fibrillary Acidic Protein/immunology | 6 | 50.0 |
Glioma/*immunology | 4 | 26.0 |
Neural Cell Adhesion Molecules/analysis | 2 | 13.0 |
Rats, Wistar | 9 | 0.0 |
Astrocytoma/metabolism | 3 | 12.0 |
Brain Neoplasms/*metabolism | 6 | 8.0 |
Formaldehyde | 3 | 3.0 |
Intermediate Filament Proteins/*metabolism | 8 | 44.0 |
Biological Markers/cerebrospinal fluid | 7 | 26.0 |
Disease Progression | 6 | 0.0 |
Glial Fibrillary Acidic Protein/*cerebrospinal fluid | 16 | 94.0 |
Neurofilament Proteins/*cerebrospinal fluid | 7 | 87.0 |
Prognosis | 13 | 0.0 |
Alzheimer Disease/*metabolism | 3 | 1.0 |
Brain/*metabolism | 3 | 0.0 |
Cadaver | 2 | 0.0 |
Electrophoresis, Gel, Two-Dimensional | 2 | 0.0 |
Nerve Tissue/metabolism | 2 | 33.0 |
Reference Values | 16 | 0.0 |
Spectrum Analysis, Mass | 2 | 0.0 |
Adenoma, Pleomorphic/metabolism/*pathology | 2 | 50.0 |
Keratin/analysis | 14 | 6.0 |
Phosphopyruvate Hydratase/analysis | 18 | 23.0 |
Vimentin/analysis | 27 | 11.0 |
Glial Fibrillary Acidic Protein/genetics/metabolism | 2 | 22.0 |
*Brain Chemistry | 9 | 5.0 |
Forensic Medicine | 2 | 3.0 |
Postmortem Changes | 5 | 7.0 |
Asphyxia Neonatorum/*cerebrospinal fluid | 2 | 66.0 |
Infant, Newborn | 17 | 0.0 |
S100 Proteins/*cerebrospinal fluid | 2 | 25.0 |
Oligodendroglioma/*genetics/*metabolism/pathology | 2 | 100.0 |
Phenotype | 17 | 0.0 |
Intermediate Filaments/*metabolism | 2 | 18.0 |
Research Support, U.S. Gov't, P.H.S. | 101 | 0.0 |
Glial Fibrillary Acidic Protein/genetics | 7 | 25.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 15 | 0.0 |
Transgenes | 3 | 0.0 |
Age of Onset | 2 | 0.0 |
Base Sequence | 15 | 0.0 |
Genotype | 3 | 0.0 |
Magnetic Resonance Imaging | 10 | 0.0 |
Mutation/*genetics | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Mice, Inbred Strains | 3 | 0.0 |
Mice, Knockout | 3 | 0.0 |
Neuroglia/*metabolism | 9 | 20.0 |
Tissue Distribution | 8 | 0.0 |
Fluorescent Dyes | 2 | 0.0 |
Injections, Intraventricular | 2 | 1.0 |
Mice, Transgenic | 7 | 0.0 |
RNA, Messenger/biosynthesis | 4 | 0.0 |
*Heat-Shock Proteins | 2 | 3.0 |
Histocytochemistry | 27 | 4.0 |
Microscopy, Electron | 35 | 1.0 |
Neoplasm Proteins/metabolism | 5 | 1.0 |
Oligodendroglioma/*metabolism/*pathology | 2 | 100.0 |
Brain/metabolism/pathology | 6 | 5.0 |
Gliosis/metabolism/pathology | 3 | 50.0 |
Fatal Outcome | 4 | 0.0 |
Tomography, X-Ray Computed | 6 | 0.0 |
Brain Neoplasms/metabolism/*pathology | 3 | 12.0 |
Retrospective Studies | 8 | 0.0 |
Follow-Up Studies | 6 | 0.0 |
Neurilemmoma/metabolism/*pathology | 2 | 28.0 |
Biopsy | 7 | 0.0 |
Cell Culture Techniques | 3 | 0.0 |
Microtubule-Associated Proteins/metabolism | 5 | 3.0 |
Neurofilament Proteins/metabolism | 6 | 10.0 |
Neurons/*metabolism/ultrastructure | 2 | 8.0 |
tau Proteins/metabolism | 2 | 2.0 |
Brain/*metabolism/ultrastructure | 2 | 33.0 |
Membrane Glycoproteins/*metabolism | 3 | 0.0 |
Immunoblotting | 6 | 0.0 |
In Situ Hybridization | 5 | 0.0 |
Mice, Inbred C57BL | 11 | 0.0 |
Mice, Transgenic/genetics | 2 | 3.0 |
Cell Count | 10 | 1.0 |
Disease Models, Animal | 13 | 0.0 |
Gliosis/pathology | 8 | 44.0 |
Survival Rate | 3 | 0.0 |
Immunoenzyme Techniques | 74 | 2.0 |
Rats, Inbred Lew | 3 | 1.0 |
Retroviridae/genetics | 2 | 0.0 |
Schwann Cells/drug effects/*metabolism/transplantation | 2 | 100.0 |
Apoptosis | 3 | 0.0 |
Cell Transformation, Neoplastic | 4 | 0.0 |
Tumor Cells, Cultured | 22 | 0.0 |
Horses | 2 | 1.0 |
Immunoenzyme Techniques/veterinary | 3 | 30.0 |
Species Specificity | 5 | 0.0 |
Tumor Markers, Biological/metabolism | 7 | 1.0 |
Chromosome Mapping | 3 | 0.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Alzheimer Disease/pathology | 3 | 13.0 |
DNA Fragmentation | 2 | 0.0 |
Nerve Growth Factors/analysis | 2 | 16.0 |
Diagnosis, Differential | 29 | 1.0 |
Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Glial Fibrillary Acidic Protein/*analysis/genetics | 2 | 100.0 |
Gene Expression Regulation/physiology | 3 | 1.0 |
Glial Fibrillary Acidic Protein/*genetics/metabolism | 5 | 83.0 |
Blood-Brain Barrier/*physiology | 2 | 5.0 |
Cattle | 6 | 0.0 |
Gene Expression/physiology | 2 | 0.0 |
RNA, Messenger/analysis | 9 | 0.0 |
Glioma/*pathology | 8 | 15.0 |
Meningeal Neoplasms/*pathology | 2 | 20.0 |
Spinal Cord/*pathology | 2 | 10.0 |
Endothelium/pathology | 2 | 9.0 |
Hyperplasia | 2 | 0.0 |
Mitosis | 2 | 0.0 |
Necrosis | 7 | 2.0 |
Neoplasm Recurrence, Local | 2 | 0.0 |
Synaptophysin/analysis | 8 | 22.0 |
Alzheimer Disease/*pathology | 3 | 5.0 |
Astrocytes/pathology | 9 | 25.0 |
Autopsy | 7 | 3.0 |
Brain/*pathology | 7 | 4.0 |
Dementia/*pathology | 5 | 35.0 |
Microglia/pathology | 4 | 40.0 |
Neurons/pathology | 9 | 8.0 |
Organ Size | 2 | 1.0 |
Senile Plaques/pathology | 3 | 8.0 |
Ubiquitins/analysis | 2 | 22.0 |
Cell Transplantation | 2 | 2.0 |
Choline O-Acetyltransferase/analysis | 3 | 6.0 |
Graft Survival | 2 | 0.0 |
Nuclear Proteins/analysis | 2 | 1.0 |
Transplantation, Heterologous | 9 | 0.0 |
Tyrosine 3-Monooxygenase/analysis | 2 | 2.0 |
*Apoptosis | 2 | 0.0 |
Biological Markers/*analysis | 2 | 1.0 |
Diabetic Retinopathy/*metabolism/pathology | 2 | 28.0 |
Membrane Glycoproteins/metabolism | 7 | 1.0 |
Protein p53/metabolism | 2 | 0.0 |
Age Factors | 15 | 0.0 |
Aging | 2 | 0.0 |
Culture Techniques | 5 | 1.0 |
Fetal Death/*pathology | 2 | 100.0 |
Pregnancy | 14 | 0.0 |
Astrocytes/chemistry | 2 | 22.0 |
Antibodies, Monoclonal/diagnostic use | 7 | 0.0 |
Brain Neoplasms/*immunology | 5 | 38.0 |
S100 Proteins/*metabolism | 2 | 3.0 |
Cell Differentiation/*physiology | 2 | 0.0 |
Chickens | 2 | 0.0 |
Gene Expression Regulation/drug effects | 2 | 0.0 |
RNA, Messenger/*genetics | 2 | 0.0 |
Vimentin/*genetics | 2 | 16.0 |
Coculture Techniques | 3 | 0.0 |
S100 Proteins/metabolism | 14 | 13.0 |
Staining and Labeling/methods | 5 | 4.0 |
Collagen/metabolism | 2 | 0.0 |
Immunophenotyping | 4 | 0.0 |
Keratin/metabolism | 8 | 5.0 |
Collagen/analysis | 2 | 2.0 |
Fibronectins/analysis | 3 | 5.0 |
Laminin/analysis | 2 | 6.0 |
Glial Fibrillary Acidic Protein/blood/immunology | 2 | 100.0 |
Calcium/metabolism | 2 | 0.0 |
Cell Differentiation/physiology | 4 | 0.0 |
Intermediate Filament Proteins/analysis | 10 | 26.0 |
Microtubule-Associated Proteins/analysis | 5 | 13.0 |
Neurofilament Proteins/analysis | 4 | 19.0 |
Tubulin/analysis | 4 | 28.0 |
*DNA-Binding Proteins | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Molecular Sequence Data | 21 | 0.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Protein Binding | 3 | 0.0 |
Protein Isoforms/metabolism | 2 | 1.0 |
*Transcription Factors | 3 | 0.0 |
*Tumor Suppressor Proteins | 2 | 0.0 |
Astrocytoma/pathology | 2 | 16.0 |
Glioblastoma/pathology | 2 | 11.0 |
Incidence | 2 | 0.0 |
Treatment Outcome | 8 | 0.0 |
Cytoskeletal Proteins/analysis | 3 | 6.0 |
Depressive Disorder, Major/*metabolism/pathology | 3 | 100.0 |
Prefrontal Cortex/*metabolism/pathology | 2 | 66.0 |
*Antigens, CD | 6 | 0.0 |
*Antigens, Neoplasm | 7 | 3.0 |
*Antigens, Surface | 5 | 7.0 |
*Avian Proteins | 5 | 5.0 |
*Blood Proteins | 5 | 6.0 |
Neuroglia/pathology | 4 | 18.0 |
Neoplasm Transplantation | 6 | 0.0 |
Rats, Inbred Strains | 7 | 0.0 |
Amyloid beta-Protein/analysis | 2 | 14.0 |
Brain Injuries/*metabolism | 3 | 27.0 |
Brain Neoplasms/*metabolism/physiopathology | 2 | 66.0 |
Cloning, Molecular | 6 | 0.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
Transgenes/*genetics | 2 | 6.0 |
Brain/metabolism | 5 | 0.0 |
von Willebrand Factor/analysis | 2 | 0.0 |
Hydrogen-Ion Concentration | 2 | 0.0 |
Immunohistochemistry/*methods | 4 | 4.0 |
Sensitivity and Specificity | 5 | 0.0 |
Drug Resistance | 2 | 0.0 |
Hippocampus/*pathology | 3 | 5.0 |
Autoantibodies/*blood | 2 | 0.0 |
Glial Fibrillary Acidic Protein/*immunology | 6 | 100.0 |
S100 Proteins/*immunology | 3 | 42.0 |
Tissue Embedding/*methods | 3 | 60.0 |
Case-Control Studies | 8 | 0.0 |
Cerebral Cortex/*abnormalities/metabolism/pathology | 2 | 100.0 |
Dyes/diagnostic use | 2 | 2.0 |
Receptors, GABA-A/metabolism | 2 | 18.0 |
Receptors, N-Methyl-D-Aspartate/metabolism | 2 | 11.0 |
Antigens, Neoplasm/*analysis | 6 | 1.0 |
Tumor Markers, Biological/*analysis | 9 | 0.0 |
Antibodies/analysis | 5 | 3.0 |
Hypoxia, Brain/*pathology | 2 | 40.0 |
Aging/physiology | 4 | 2.0 |
Brain/*enzymology | 2 | 1.0 |
Brain Chemistry/physiology | 3 | 11.0 |
Schwann Cells/*metabolism | 2 | 12.0 |
Cell Culture Techniques/*methods | 3 | 3.0 |
Glial Fibrillary Acidic Protein/*analysis | 42 | 93.0 |
Lateral Ventricles/pathology | 2 | 100.0 |
Brain/*metabolism/pathology | 5 | 6.0 |
Gene Expression | 8 | 0.0 |
*Mice, Transgenic | 2 | 4.0 |
Mutation | 5 | 0.0 |
Alzheimer Disease/*enzymology/pathology | 2 | 6.0 |
Lectins/metabolism | 3 | 3.0 |
Glioma/metabolism/*pathology | 3 | 23.0 |
Astrocytes/*pathology | 5 | 31.0 |
Brain/cytology/*pathology | 2 | 100.0 |
Gliosis/*pathology | 3 | 100.0 |
Neurofibrillary Tangles/pathology | 2 | 3.0 |
Cell Death | 2 | 0.0 |
Dark Adaptation | 2 | 5.0 |
Electroretinography | 3 | 1.0 |
Fibroblast Growth Factor 2/metabolism | 2 | 2.0 |
Vimentin/metabolism | 14 | 13.0 |
Cytoskeleton/metabolism | 2 | 0.0 |
*Gene Expression | 2 | 0.0 |
Glial Fibrillary Acidic Protein/analysis/*genetics | 3 | 100.0 |
In Situ Nick-End Labeling | 3 | 0.0 |
Macaca fascicularis | 3 | 1.0 |
Transplantation, Autologous | 2 | 0.0 |
*Disease Models, Animal | 3 | 0.0 |
Cerebral Cortex/cytology | 2 | 8.0 |
Electrophoresis | 2 | 0.0 |
Interleukin-1/*pharmacology | 2 | 0.0 |
Promoter Regions (Genetics)/genetics | 2 | 0.0 |
Rats, Inbred F344 | 6 | 1.0 |
Transcription, Genetic/drug effects | 3 | 0.0 |
Astrocytes/*metabolism/pathology | 3 | 27.0 |
Biological Markers/*cerebrospinal fluid | 2 | 50.0 |
Glial Fibrillary Acidic Protein/cerebrospinal fluid | 2 | 100.0 |
Neurons/*metabolism/pathology | 4 | 7.0 |
Phosphopyruvate Hydratase/cerebrospinal fluid | 2 | 40.0 |
S100 Proteins/cerebrospinal fluid | 2 | 22.0 |
Antibodies, Monoclonal/pharmacology | 2 | 0.0 |
Choline O-Acetyltransferase/metabolism | 2 | 1.0 |
Microglia/metabolism | 3 | 13.0 |
Evaluation Studies | 2 | 0.0 |
Tumor Markers, Biological/analysis | 10 | 1.0 |
Alleles | 3 | 0.0 |
Neuroglia/*physiology | 7 | 25.0 |
Astrocytes/metabolism | 4 | 5.0 |
Brain/metabolism/*pathology | 3 | 9.0 |
Cerebellum/metabolism/pathology | 2 | 22.0 |
Cerebral Cortex/metabolism/pathology | 2 | 11.0 |
Heterozygote | 3 | 0.0 |
Hippocampus/metabolism/pathology | 2 | 6.0 |
Mice, Neurologic Mutants | 3 | 2.0 |
Tubulin/metabolism | 2 | 2.0 |
Cell Division/drug effects | 4 | 0.0 |
Glial Fibrillary Acidic Protein/*biosynthesis/genetics | 3 | 100.0 |
Adenoviridae/genetics | 2 | 0.0 |
Cell Division | 8 | 0.0 |
Glial Fibrillary Acidic Protein/*biosynthesis | 6 | 100.0 |
Antigens, Neoplasm/metabolism | 3 | 4.0 |
Cell Movement | 2 | 0.0 |
Dose-Response Relationship, Drug | 4 | 0.0 |
Transcription, Genetic/*drug effects | 2 | 0.0 |
Aging/*physiology | 4 | 1.0 |
Astrocytes/*cytology | 2 | 25.0 |
Cytoskeleton/*ultrastructure | 3 | 25.0 |
Immunologic Techniques | 5 | 1.0 |
Neurons/cytology | 2 | 4.0 |
Astrocytoma/*metabolism | 6 | 24.0 |
Oligodendroglia/metabolism | 2 | 4.0 |
Oligodendroglioma/metabolism | 2 | 40.0 |
Up-Regulation | 3 | 0.0 |
Cell Differentiation | 18 | 0.0 |
Survival Analysis | 3 | 0.0 |
Aging/*metabolism | 3 | 1.0 |
Antibodies/*immunology | 2 | 1.0 |
Cross Reactions | 2 | 0.0 |
Swine | 4 | 0.0 |
Ectoderm | 2 | 16.0 |
Alzheimer Disease/*metabolism/pathology | 3 | 3.0 |
Microscopy, Immunoelectron | 7 | 1.0 |
alpha 1-Antichymotrypsin/*analysis | 2 | 40.0 |
Astrocytes/physiology | 4 | 26.0 |
Cell Communication/physiology | 2 | 2.0 |
Hypothalamus/metabolism | 2 | 4.0 |
Neurons/physiology | 3 | 2.0 |
RNA, Messenger/metabolism | 6 | 0.0 |
Recombinant Proteins | 2 | 0.0 |
Loss of Heterozygosity/genetics | 2 | 1.0 |
Mitotic Index | 2 | 1.0 |
Antibodies, Monoclonal/immunology | 4 | 0.0 |
Glioblastoma/*metabolism | 3 | 9.0 |
Intermediate Filament Proteins/immunology/*metabolism | 2 | 100.0 |
Amino Acid Sequence | 13 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 16 | 0.0 |
Glioma/*chemistry | 2 | 28.0 |
Gliosis/cerebrospinal fluid | 2 | 100.0 |
Embryonic and Fetal Development | 4 | 1.0 |
Cerebrospinal Fluid Proteins/*analysis | 2 | 20.0 |
Multiple Sclerosis/*cerebrospinal fluid | 2 | 12.0 |
Macaca mulatta | 3 | 0.0 |
Morphogenesis | 2 | 0.0 |
Astrocytoma/chemistry/*pathology | 2 | 100.0 |
Nerve Tissue Proteins/metabolism | 6 | 2.0 |
Astrocytes/metabolism/*pathology | 3 | 42.0 |
Brain Diseases/*pathology | 2 | 28.0 |
Hypertrophy | 3 | 2.0 |
Tumor Cells, Cultured/*pathology | 2 | 10.0 |
von Willebrand Factor/metabolism | 2 | 0.0 |
Prions/*genetics | 2 | 3.0 |
Statistics, Nonparametric | 3 | 0.0 |
Frontal Lobe/pathology | 2 | 20.0 |
Recurrence | 2 | 0.0 |
Catecholamines/metabolism | 3 | 6.0 |
Analysis of Variance | 6 | 0.0 |
Astrocytes/*physiology | 5 | 27.0 |
Laterality | 3 | 5.0 |
Neurons/*physiology | 3 | 2.0 |
Oxidopamine | 2 | 4.0 |
S100 Proteins/biosynthesis | 2 | 28.0 |
Tyrosine 3-Monooxygenase/metabolism | 3 | 1.0 |
Fluorescent Antibody Technique | 18 | 0.0 |
Mice, Nude | 4 | 0.0 |
Nerve Tissue Proteins/*analysis | 6 | 7.0 |
Brain Ischemia/*pathology | 3 | 42.0 |
Cerebral Cortex/*pathology | 4 | 13.0 |
Receptors, Estrogen/analysis | 3 | 0.0 |
Receptors, Progesterone/analysis | 3 | 1.0 |
Antibodies, Monoclonal | 13 | 0.0 |
Glial Fibrillary Acidic Protein/*biosynthesis/ultrastructure | 2 | 100.0 |
Fetus/metabolism | 3 | 1.0 |
Myelin Basic Proteins/metabolism | 3 | 5.0 |
Epithelium/chemistry/pathology | 2 | 5.0 |
Pregnancy Trimester, Second | 2 | 0.0 |
Epitopes/immunology | 3 | 0.0 |
Intermediate Filament Proteins/immunology | 2 | 25.0 |
Molecular Weight | 7 | 0.0 |
Gestational Age | 12 | 1.0 |
Nerve Degeneration/physiology | 3 | 16.0 |
Factor VIII/metabolism | 2 | 2.0 |
Carcinoembryonic Antigen/analysis | 4 | 3.0 |
Staining and Labeling | 11 | 1.0 |
Chi-Square Distribution | 2 | 0.0 |
Sudden Infant Death/*pathology | 2 | 16.0 |
Autoradiography | 3 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Sex Factors | 2 | 0.0 |
Alzheimer Disease/*cerebrospinal fluid | 2 | 11.0 |
*Frontal Lobe | 3 | 50.0 |
Peripheral Nervous System Diseases/*metabolism/pathology | 2 | 40.0 |
*Antibodies, Monoclonal | 2 | 0.0 |
Neovascularization, Pathologic | 2 | 0.0 |
Brain/pathology/*physiopathology | 2 | 28.0 |
Mice, Mutant Strains/genetics | 2 | 20.0 |
*Neuronal Plasticity | 2 | 10.0 |
Oligodendroglia/metabolism/pathology | 2 | 28.0 |
Astrocytes/chemistry/*cytology | 2 | 50.0 |
Cytoskeletal Proteins/metabolism | 2 | 0.0 |
Cerebral Infarction/pathology | 3 | 30.0 |
Methylation | 2 | 0.0 |
Transfection | 3 | 0.0 |
*Cell Differentiation | 2 | 0.0 |
Glial Fibrillary Acidic Protein/diagnostic use | 2 | 100.0 |
*Immunohistochemistry | 2 | 2.0 |
Neuroglia/*pathology | 2 | 15.0 |
Flow Cytometry | 3 | 0.0 |
Ploidies | 2 | 0.0 |
Chromosomes, Human, Pair 22 | 2 | 1.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Actins/*metabolism | 3 | 1.0 |
Hamsters | 3 | 0.0 |
Tuberous Sclerosis/*pathology | 3 | 42.0 |
Myelin Sheath/physiology | 2 | 11.0 |
HLA-DR Antigens/analysis | 2 | 0.0 |
Brain Neoplasms/*pathology/ultrastructure | 2 | 100.0 |
S100 Proteins/*analysis | 7 | 15.0 |
*Gene Expression Regulation | 2 | 0.0 |
Glial Fibrillary Acidic Protein/biosynthesis/genetics | 2 | 50.0 |
Nerve Degeneration | 3 | 4.0 |
*Protein Biosynthesis | 2 | 0.0 |
Cell Line | 12 | 0.0 |
Prospective Studies | 2 | 0.0 |
Guinea Pigs | 2 | 0.0 |
Histocompatibility Antigens Class II/analysis | 2 | 1.0 |
Antigens/*analysis | 3 | 3.0 |
*Microwaves | 2 | 10.0 |
Alzheimer Disease/*genetics/pathology | 2 | 6.0 |
RNA, Messenger/*metabolism | 4 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
Alzheimer Disease/*immunology | 3 | 21.0 |
Immunochemistry | 5 | 2.0 |
Cell Adhesion Molecules, Neuronal/metabolism | 2 | 18.0 |
Epithelium/metabolism | 2 | 0.0 |
Cerebral Cortex/ultrastructure | 2 | 33.0 |
Macrophages/pathology | 2 | 1.0 |
Blotting, Southern | 2 | 0.0 |
Endothelium, Vascular/metabolism/pathology | 2 | 3.0 |
Fetal Tissue Transplantation/*physiology | 3 | 30.0 |
Rats, Nude | 2 | 4.0 |
Phosphopyruvate Hydratase/*analysis | 5 | 25.0 |
Vimentin/*analysis | 3 | 25.0 |
Central Nervous System/*embryology | 2 | 11.0 |
Neurons/metabolism | 2 | 0.0 |
Phosphopyruvate Hydratase/metabolism | 7 | 13.0 |
Consensus Sequence | 2 | 0.0 |
Nerve Tissue Proteins/analysis | 4 | 5.0 |
Brain/growth & development/*metabolism | 2 | 7.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Muscle, Smooth/pathology | 2 | 9.0 |
CA-15-3 Antigen | 7 | 7.0 |
Membrane Glycoproteins/analysis | 4 | 1.0 |
Tumor Markers, Biological | 3 | 0.0 |
Encephalitis/cerebrospinal fluid | 2 | 50.0 |
Cerebral Cortex/pathology | 5 | 10.0 |
Nucleolus Organizer Region/*ultrastructure | 2 | 10.0 |
Astrocytes/ultrastructure | 3 | 75.0 |
Sclerosis | 2 | 3.0 |
Desmin/metabolism | 3 | 12.0 |
Keratin/*metabolism | 2 | 6.0 |
Proteochondroitin Sulfates/metabolism | 2 | 16.0 |
Vimentin/*metabolism | 2 | 13.0 |
Hippocampus/pathology | 2 | 5.0 |
Glial Fibrillary Acidic Protein/immunology/*metabolism | 4 | 100.0 |
Aging/metabolism | 4 | 2.0 |
Neurons/*metabolism | 2 | 0.0 |
*Nerve Degeneration | 2 | 8.0 |
Astrocytes/*ultrastructure | 3 | 42.0 |
Glial Fibrillary Acidic Protein/immunology/metabolism | 3 | 42.0 |
Antigens, Neoplasm/immunology | 2 | 1.0 |
Cell Nucleus/ultrastructure | 3 | 2.0 |
*Chromosome Mapping | 2 | 0.0 |
Antigens, Neoplasm/analysis | 2 | 0.0 |
Anoxia/pathology | 2 | 66.0 |
Peanut Agglutinin | 2 | 6.0 |
*Plant Lectins | 3 | 2.0 |
Brain Neoplasms/metabolism/*ultrastructure | 2 | 100.0 |
Cell Transformation, Neoplastic/*pathology | 2 | 7.0 |
Desmin/analysis | 3 | 4.0 |
Ependyma/pathology | 2 | 50.0 |
Cytoplasm/ultrastructure | 2 | 3.0 |
Intermediate Filament Proteins/*analysis | 11 | 55.0 |
Intermediate Filaments/ultrastructure | 2 | 18.0 |
DNA | 2 | 0.0 |
Nucleic Acid Hybridization | 4 | 0.0 |
Fetus | 5 | 0.0 |
Tuberous Sclerosis/*complications | 2 | 40.0 |
Glioma/*metabolism | 3 | 6.0 |
Tumor Cells, Cultured/metabolism | 3 | 1.0 |
Keratin/*analysis | 3 | 10.0 |
Neoplasms, Germ Cell and Embryonal/*metabolism | 2 | 33.0 |
Membrane Glycoproteins/*analysis | 2 | 1.0 |
Galactosylceramides/analysis | 2 | 22.0 |
Receptors, Nerve Growth Factor | 3 | 6.0 |
Immunoelectrophoresis | 3 | 1.0 |
Risk Factors | 2 | 0.0 |
Vimentin/*immunology | 2 | 100.0 |
Immune Sera | 3 | 1.0 |
Intermediate Filament Proteins/metabolism | 10 | 21.0 |
Intermediate Filaments/metabolism | 2 | 40.0 |
Microscopy, Fluorescence | 7 | 0.0 |
Hybridomas/immunology | 2 | 1.0 |
Radioimmunoassay | 4 | 0.0 |
Chromogranins/metabolism | 2 | 6.0 |
*Embryonic and Fetal Development | 3 | 2.0 |
Antigens, CD57 | 4 | 6.0 |
Antigens, Differentiation/analysis | 4 | 1.0 |
Myelin Basic Proteins/analysis | 7 | 25.0 |
Rabbits | 2 | 0.0 |
Antibodies, Monoclonal/*diagnostic use | 2 | 0.0 |
Neurofilament Proteins | 9 | 40.0 |
Amyloid beta-Protein/*metabolism | 2 | 2.0 |
Astrocytes/cytology | 3 | 20.0 |
Glutamate-Ammonia Ligase/analysis | 2 | 66.0 |
Skin Neoplasms/chemistry/*pathology | 2 | 4.0 |
Astrocytes/analysis | 4 | 100.0 |
Brain Neoplasms/analysis/*pathology | 3 | 100.0 |
Oligodendroglia/analysis | 3 | 60.0 |
Oligodendroglioma/analysis/*pathology | 2 | 100.0 |
Atrophy | 2 | 1.0 |
Cerebral Ventricle Neoplasms/*pathology | 2 | 100.0 |
*Choroid Plexus | 3 | 75.0 |
Cause of Death | 2 | 1.0 |
Silver | 2 | 10.0 |
Neoplasm Proteins/*analysis | 5 | 1.0 |
Teratoma/*analysis/pathology | 2 | 50.0 |
Receptors, Cell Surface/metabolism | 2 | 0.0 |
Astrocytoma/*metabolism/pathology | 2 | 9.0 |
Immune Sera/immunology | 2 | 1.0 |
Nerve Tissue Proteins/*metabolism | 4 | 1.0 |
Synaptophysin | 3 | 30.0 |
tau Proteins | 3 | 17.0 |
Statistics | 2 | 0.0 |
Carbonic Anhydrases/metabolism | 2 | 14.0 |
Eye Enucleation | 2 | 15.0 |
Astrocytoma/*pathology | 2 | 12.0 |
Epithelium/pathology | 2 | 1.0 |
Microtubule-Associated Proteins/*analysis | 2 | 9.0 |
Neoplasm Metastasis | 2 | 0.0 |
Astrocytoma/*analysis/pathology | 3 | 100.0 |
Glioblastoma/*analysis/pathology | 2 | 100.0 |
Brain Neoplasms/*analysis/pathology | 5 | 62.0 |
*Nerve Regeneration | 2 | 14.0 |
Brain Neoplasms/immunology/*metabolism | 3 | 75.0 |
*HIV-1 | 2 | 0.0 |
Lectins/analysis | 2 | 13.0 |
Myelin-Associated Glycoprotein | 3 | 2.0 |
Glial Fibrillary Acidic Protein/*analysis/immunology | 2 | 100.0 |
Myelin Proteins/analysis | 2 | 22.0 |
Schwann Cells/analysis | 2 | 66.0 |
Factor VIII/immunology | 3 | 33.0 |
Cytoskeleton/*analysis | 2 | 28.0 |
Astrocytes/analysis/*physiology | 2 | 100.0 |
Antigens, Neoplasm/*metabolism | 2 | 2.0 |
Fibronectins/metabolism | 4 | 2.0 |
Frozen Sections | 2 | 2.0 |
Galactosylceramides/metabolism | 2 | 14.0 |
Neoplasm Proteins/*metabolism | 2 | 0.0 |
alpha-Fetoproteins/analysis | 2 | 0.0 |
Laminin/metabolism | 3 | 2.0 |
Subacute Sclerosing Panencephalitis/cerebrospinal fluid | 2 | 100.0 |
Brain Neoplasms/*analysis | 4 | 57.0 |
Myelin Basic Proteins/*analysis | 5 | 33.0 |
Cerebellar Neoplasms/*analysis | 2 | 100.0 |
Medulloblastoma/*analysis | 2 | 66.0 |
Astrocytes/*immunology | 4 | 30.0 |
Dementia/cerebrospinal fluid | 3 | 50.0 |
Astrocytoma/analysis/pathology | 2 | 66.0 |
Multiple Sclerosis/cerebrospinal fluid | 2 | 28.0 |
Astrocytoma/*analysis | 2 | 66.0 |
Central Nervous System/immunology | 2 | 14.0 |
Multiple Sclerosis/immunology | 2 | 4.0 |
Astrocytoma/analysis | 2 | 66.0 |
*Cell Division | 2 | 1.0 |
Meningioma/analysis | 2 | 50.0 |
Factor VIII/analysis/*immunology | 2 | 25.0 |
von Willebrand Factor | 4 | 14.0 |
*Immunoenzyme Techniques | 2 | 1.0 |
Glial Fibrillary Acidic Protein | 15 | 75.0 |
Neuroglia/*cytology | 2 | 22.0 |
Vimentin | 4 | 80.0 |
Intermediate Filament Proteins/*immunology | 2 | 25.0 |
Glycoproteins/metabolism | 2 | 1.0 |
Neurofibromatosis 1/*ultrastructure | 2 | 100.0 |
Skin/ultrastructure | 2 | 9.0 |
Skin Neoplasms/*ultrastructure | 2 | 100.0 |
Antigens | 2 | 2.0 |
Glioma/immunology/*metabolism | 2 | 50.0 |
Cerebellar Neoplasms/metabolism | 2 | 40.0 |
Cranial Fossa, Posterior | 2 | 50.0 |
Fibronectins/*metabolism | 2 | 2.0 |
Hemangiopericytoma/*metabolism | 2 | 100.0 |
Hemangiosarcoma/*metabolism | 2 | 100.0 |
*Medulla Oblongata | 2 | 66.0 |
Spinal Cord Neoplasms/*metabolism | 2 | 100.0 |
Fibronectins/*analysis | 2 | 9.0 |
Receptors, Neurotransmitter/metabolism | 2 | 11.0 |
